| Stage | MSA | % of rev | ISRG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $503M | 100.00% | $3.0B | 100.00% | ISRG ×6.06 |
| Gross profit | $249M | 49.53% | $2.1B | 68.37% | ISRG +18.8pp |
| Operating income | $112M | 22.24% | $593M | 19.44% | MSA +2.8pp |
| Pre-tax income | $111M | 22.13% | $668M | 21.92% | MSA +0.2pp |
| Net income | $86M | 17.12% | $524M | 17.20% | ISRG +0.1pp |
| Stage | MSA | ISRG | Gap · A − B |
|---|---|---|---|
| Revenue | $503M100.00% | $3.0B100.00% | ISRG ×6.06 |
| Gross profit | 49.53%$249M | 68.37%$2.1B | ISRG +18.8pp |
| Operating income | 22.24%$112M | 19.44%$593M | MSA +2.8pp |
| Pre-tax income | 22.13%$111M | 21.92%$668M | MSA +0.2pp |
| Net income |
| 17.12%$86M |
| 17.20%$524M |
| ISRG +0.1pp |
No shared counterparties.